Literature DB >> 19396496

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

Mark P Callery1, Kenneth J Chang, Elliot K Fishman, Mark S Talamonti, L William Traverso, David C Linehan.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19396496     DOI： 10.1245/s10434-009-0408-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  254 in total

1.  Diagnosing and managing pancreatic cancer.

Authors:  Matthew T Huggett; Stephen P Pereira
Journal:  Practitioner       Date:  2011 Jul-Aug

2.  Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer.

Authors:  Chang Moo Kang; Yong Eun Chung; Jeong Youp Park; Jin Sil Sung; Ho Kyoung Hwang; Hye Jin Choi; Hyunki Kim; Si Young Song; Woo Jung Lee
Journal:  J Gastrointest Surg       Date:  2011-12-20       Impact factor: 3.452

3.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

Review 4.  Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.

Authors:  Francesco A D'Angelo; Laura Antolino; Mara La Rocca; Niccolò Petrucciani; Paolo Magistri; Paolo Aurello; Giovanni Ramacciato
Journal:  Med Oncol       Date:  2016-02-17       Impact factor: 3.064

Review 5.  Borderline resectable pancreatic cancer: definitions and management.

Authors:  Nicole E Lopez; Cristina Prendergast; Andrew M Lowy
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

6.  Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer.

Authors:  Charles C Hsu; Christopher L Wolfgang; Daniel A Laheru; Timothy M Pawlik; Michael J Swartz; Jordan M Winter; Raymond Robinson; Barish H Edil; Amol K Narang; Michael A Choti; Ralph H Hruban; John L Cameron; Richard D Schulick; Joseph M Herman
Journal:  J Gastrointest Surg       Date:  2012-02-07       Impact factor: 3.452

7.  Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.

Authors:  Sonali Rudra; Amol K Narang; Timothy M Pawlik; Hao Wang; Elizabeth M Jaffee; Lei Zheng; Dung T Le; David Cosgrove; Ralph H Hruban; Elliot K Fishman; Richard Tuli; Daniel A Laheru; Christopher L Wolfgang; Luis A Diaz; Joseph M Herman
Journal:  Pract Radiat Oncol       Date:  2012

8.  Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.

Authors:  Pavlos Papavasiliou; John P Hoffman; Steven J Cohen; Joshua E Meyer; James C Watson; Yun Shin Chun
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

9.  Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head.

Authors:  Quentin Denost; Christophe Laurent; Jean-Philippe Adam; Maylis Capdepont; Veronique Vendrely; Denis Collet; Antonio Sa Cunha
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

10.  Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression.

Authors:  Vikas Dudeja; Edward W Greeno; Sidney P Walker; Eric H Jensen
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.